Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
Immune checkpoint inhibitors have entailed a change of paradigm in the management of multiple malignant diseases and are acquiring a key role in an increasing number of clinical sceneries. However, since their mechanism of action is not limited to the tumor microenvironment, their systemic activity...
Main Authors: | Víctor Albarrán, Jesús Chamorro, Diana Isabel Rosero, Cristina Saavedra, Ainara Soria, Alfredo Carrato, Pablo Gajate |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.774170/full |
Similar Items
-
Management of Dermatologic Toxicities Related to Immune Checkpoint Inhibitors
by: Xiaoyan SI, et al.
Published: (2019-10-01) -
Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma
by: Antonio Farina, et al.
Published: (2024-01-01) -
Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers
by: Haoran Li, et al.
Published: (2022-05-01) -
Imaging assessment of toxicity related to immune checkpoint inhibitors
by: Antonia M. Berz, et al.
Published: (2023-02-01) -
Skin manifestations associated with checkpoint inhibitors
by: Gianluca Nazzaro, et al.
Published: (2022-06-01)